CGBIO, a leading bio-regenerative medicine company, recently hosted a hands-on seminar for dental professionals titled, GBR is Not Intuition, It’s Engineering: All About Dr. Teddy, the company announced on Tuesday.
This seminar went beyond traditional lecture-style education, focusing on practical demonstrations and hands-on training to enhance participants’ understanding and clinical application skills in maxillary sinus lift and bone grafting procedures.
Dr. Lee Seung-keun, director of Gongneung Seoul Dental Clinic, led the lecture, which centered on clinical application strategies and real-world cases of maxillary sinus lift and bone grafting techniques. Attendees had the unique opportunity to perform the entire procedure during the hands-on program, allowing them to validate specific application points in clinical scenarios.
During the seminar, CGBIO showcased various clinical cases and application methods featuring their innovative injectable bone graft material, ExcelOs Inject. Participants gained firsthand experience by practicing injection and filling processes, confirming the product’s ease of use and clinical versatility on-site.
ExcelOs Inject is engineered to maintain space and stimulate new bone formation in areas of bone deficiency. Its distinctive hydrogel formulation, which possesses a unique viscosity, ensures both injectability and stability – advantages over traditional particulate bone graft materials.
These properties prove particularly beneficial in procedures requiring precision, such as maxillary sinus lifts. While conventional hydraulic elevation methods may result in uneven membrane elevation when using low-viscosity materials, ExcelOs Inject promotes more stable elevation through its viscous properties, enhancing procedural safety and predictability. Moreover, post-procedure radiographic imaging facilitates easier confirmation of the filling status, increasing its utility in clinical evaluations.
CGBIO is committed to continuously strengthening its clinical education programs alongside product innovation in the dental bone graft materials sector. This initiative aims to help dental professionals better understand product characteristics and application methods, ultimately enhancing their practical use in clinical settings.
Chief Executive Officer (CEO) Yoo Hyun-seung stated that this hands-on seminar provided dental professionals with a unique opportunity to directly observe the properties of ExcelOs Inject and explore its practical applications in real-world procedures. It will continue to expand the clinical education and academic exchanges to provide cutting-edge clinical solutions in the field of dental regenerative medicine.
